Home NDC 70518-2869-2 NDC 70518-2869-2 - Aripiprazole This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 70518-2869
Requested NDC 70518-2869-2
Package NDCs from labels 70518-2869-0, 70518-2869-2, 70518-2869-1
Manufacturer REMEDYREPACK INC.
Effective date 2026-07-30
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Labels# Label, Manufacturer, Effective date table Label Manufacturer Effective date Type Aripiprazole - REMEDYREPACK INC. REMEDYREPACK INC. 2026-07-30 HUMAN PRESCRIPTION DRUG LABEL
FDA-Initiated Inactive NDC Indexing# NDC, Effective, Related label table NDC Effective Related label 70518-2869-0 2022-02-08 These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002 70518-2869-0 2022-02-08 These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002 70518-2869-0 2022-02-08 These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002 70518-2869-1 2022-02-08 These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002 70518-2869-1 2022-02-08 These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002 70518-2869-1 2022-02-08 These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002 70518-2869-0 2022-01-28 These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002 70518-2869-0 2022-01-28 These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002 70518-2869-0 2022-01-28 These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002 70518-2869-1 2022-01-28 These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002 70518-2869-1 2022-01-28 These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002 70518-2869-1 2022-01-28 These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 70518-2869-0 Aripiprazole 30 in 1 BLISTER PACK TABLET 30 11 70518-2869-1 Aripiprazole 30 in 1 BOX TABLET 30 11 70518-2869-2 Aripiprazole 1 in 1 POUCH TABLET 1 11
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 70518-2869 ARIPIPRAZOLE TABLET [REMEDYREPACK INC.] 8 Current NDC, Legacy NDC, 3 package rows 20250503_bc3fde41-2f24-44e2-815d-15fe55bd68b3.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 7 of 7 · 123 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Aripiprazole ARIPIPRAZOLE Proficient Rx LP dbdc8fbe-c75f-4f17-a2cd-9f23802dcc5d 2019-11-01 Boxed warning, Warnings, Adverse reactions Exact identifier rxcui: 602964 unii: 82VFR53I78 Aripiprazole ARIPIPRAZOLE Exelan Pharmaceuticals, Inc. 705190bf-9f9d-4183-a56b-4eeafeacde59 2018-12-28 Boxed warning, Warnings, Adverse reactions Exact identifier rxcui: 349547 rxcui: 349553 rxcui: 602964 rxcui: 349545 rxcui: 349490 rxcui: 402131 unii: 82VFR53I78 ARIPIPRAZOLE ARIPIPRAZOLE Camber Pharmaceuticals, Inc. 3718e585-06b9-40fd-a3eb-18b6497a4235 2017-08-08 Boxed warning, Warnings, Adverse reactions Exact identifier rxcui: 349547 rxcui: 349553 rxcui: 602964 rxcui: 349545 rxcui: 349490 rxcui: 402131 unii: 82VFR53I78
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.